Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corticosteroid Injection vs Splinting for Rheumatic CTS
NCT07042282Not yet recruiting
- Start
- Aug 2025
- Primary completion
- Aug 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of triamcinolone acetonide in carpal tunnel syndrome (CTS) (2 arms). Primary endpoints: Boston Carpal Tunnel Questionnaire Function Status Subscale at 6 weeks and Boston Carpal Tunnel Questionnaire Symptom Severity Subscale at 6 weeks. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
triamcinolone acetonide
03
Conditions
carpal tunnel syndrome (CTS)
Beyond the preview
Go deeper on NCT07042282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07042282.